# Novartis' Biotech Investments: 51 Startups in Its Portfolio (2026) > The 51 Biotech startups Novartis has backed, by stage: $5.4B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/novartis-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 14 - [Freenome](https://millionrounds.com/company/freenome) - [Dren Bio](https://millionrounds.com/company/dren-bio) - [C4 Therapeutics](https://millionrounds.com/company/c4-therapeutics) - [Lightship](https://millionrounds.com/company/lightship) - [*A* Anokion](https://millionrounds.com/company/anokion) - [Alladapt Immunotherapeutics](https://millionrounds.com/company/alladapt-immunotherapeutics) - [*I* Inflazome](https://millionrounds.com/company/inflazome) - [Credence MedSystems](https://millionrounds.com/company/credence-medsystems) - [Holmusk](https://millionrounds.com/company/holmusk) - [Cavion](https://millionrounds.com/company/cavion) - [CODA Biotherapeutics](https://millionrounds.com/company/coda-biotherapeutics) - [Xealth](https://millionrounds.com/company/xealth) - [*M* Macrolide](https://millionrounds.com/company/macrolide) - [*A* Anaeropharma](https://millionrounds.com/company/anaeropharma) ## Series A 14 - [GentiBio](https://millionrounds.com/company/gentibio) - [Caribou Biosciences](https://millionrounds.com/company/caribou-biosciences) - [Rhygaze](https://millionrounds.com/company/rhygaze) - [IFM Therapeutics](https://millionrounds.com/company/ifm-therapeutics) - [*CT* CoDa Therapeutics](https://millionrounds.com/company/coda-therapeutics) - [Alesta Therapeutics](https://millionrounds.com/company/alesta-therapeutics) - [Tagworks Pharmaceuticals](https://millionrounds.com/company/tagworks-pharmaceuticals) - [*A* Akuous](https://millionrounds.com/company/akuous) - [Renovacor](https://millionrounds.com/company/renovacor) - [Dunad Therapeutics](https://millionrounds.com/company/dunad-therapeutics) - [*AT* Aelin Therapeutics](https://millionrounds.com/company/aelin-therapeutics) - [Forendo Pharma](https://millionrounds.com/company/forendo-pharma) - [Dopavision](https://millionrounds.com/company/dopavision) - [*N* NeuroVia](https://millionrounds.com/company/neurovia) ## Series B 13 - [Intellia Therapeutics](https://millionrounds.com/company/intellia-therapeutics) - [Aktis Oncology](https://millionrounds.com/company/aktis-oncology) - [Mediar Therapeutics](https://millionrounds.com/company/mediar-therapeutics) - [Semma Therapeutics](https://millionrounds.com/company/semma-therapeutics) - [Homology Medicines](https://millionrounds.com/company/homology-medicines) - [Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics) - [Citryll](https://millionrounds.com/company/citryll) - [Artios](https://millionrounds.com/company/artios) - [*GB* Granite Bio](https://millionrounds.com/company/granite-bio) - [*AP* Ayala Pharmaceuticals](https://millionrounds.com/company/ayala-pharmaceuticals) - [*O* Oculis](https://millionrounds.com/company/oculis) - [Aspen RxHealth](https://millionrounds.com/company/aspen-rxhealth) - [Aravax](https://millionrounds.com/company/aravax) ## Series C and later 10 - [Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences) - [Pear Therapeutics](https://millionrounds.com/company/pear-therapeutics) - [Science 37](https://millionrounds.com/company/science-37) - [Rani Therapeutics](https://millionrounds.com/company/rani-therapeutics) - [Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics) - [ONL Therapeutics](https://millionrounds.com/company/onl-therapeutics) - [Cota](https://millionrounds.com/company/cota) - [Orionis Biosciences](https://millionrounds.com/company/orionis-biosciences) - [*SS* Seventh Sense Biosystems](https://millionrounds.com/company/seventh-sense-biosystems) - [*CB* Covalys Biosciences](https://millionrounds.com/company/covalys-biosciences) ## Segment by segment ### Stage not reported 14 startups · $1.5B raised - [**Freenome**](https://millionrounds.com/company/freenome) Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw. United States $553M - [**Dren Bio**](https://millionrounds.com/company/dren-bio) Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. United States $375M - [**C4 Therapeutics**](https://millionrounds.com/company/c4-therapeutics) C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins. United States $125M - [**Lightship**](https://millionrounds.com/company/lightship) Lightship is an all-electric RV manufacturer, designer, and a producer of an aerodynamic, battery-powered trailer for the electric age. United States $77M - [*A* **Anokion**](https://millionrounds.com/company/anokion) Switzerland $75M - [**Alladapt Immunotherapeutics**](https://millionrounds.com/company/alladapt-immunotherapeutics) Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy. United States $50M - [*I* **Inflazome**](https://millionrounds.com/company/inflazome) Ireland $46M - [**Credence MedSystems**](https://millionrounds.com/company/credence-medsystems) Credence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely. United States $41M ### Series A 14 startups · $884M raised - [**GentiBio**](https://millionrounds.com/company/gentibio) GentiBio is a clinical-stage biotherapeutics company founded in 2020, focused on developing engineered regulatory T-cell therapies United States $157M - [**Caribou Biosciences**](https://millionrounds.com/company/caribou-biosciences) Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology. United States $139M - [**Rhygaze**](https://millionrounds.com/company/rhygaze) RhyGaze is a biotechnology company based in Basel, Switzerland, and Philadelphia, Pennsylvania, founded in 2024. Switzerland $86M - [**IFM Therapeutics**](https://millionrounds.com/company/ifm-therapeutics) IFM Therapeutics is a biopharmaceutical company based in Boston, Massachusetts, focused on developing innovative therapies for can United States $83M - [*CT* **CoDa Therapeutics**](https://millionrounds.com/company/coda-therapeutics) United States $78M - [**Alesta Therapeutics**](https://millionrounds.com/company/alesta-therapeutics) Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic. Netherlands $67M - [**Tagworks Pharmaceuticals**](https://millionrounds.com/company/tagworks-pharmaceuticals) Tagworks Pharmaceuticals is a clinical-stage precision oncology company based in Nijmegen, Netherlands, with operations in Boston, U.S. Netherlands $65M - [*A* **Akuous**](https://millionrounds.com/company/akuous) United States $50M ### Series B 13 startups · $1.6B raised - [**Intellia Therapeutics**](https://millionrounds.com/company/intellia-therapeutics) Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. United States $485M - [**Aktis Oncology**](https://millionrounds.com/company/aktis-oncology) Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals. United States $175M - [**Mediar Therapeutics**](https://millionrounds.com/company/mediar-therapeutics) Mediar Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2018-2019. United States $161M - [**Semma Therapeutics**](https://millionrounds.com/company/semma-therapeutics) Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. United States $158M - [**Homology Medicines**](https://millionrounds.com/company/homology-medicines) Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases. United States $144M - [**Bicycle Therapeutics**](https://millionrounds.com/company/bicycle-therapeutics) Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics. United Kingdom $110M - [**Citryll**](https://millionrounds.com/company/citryll) Citryll is a biotechnology company based in Oss, Netherlands, founded in 2015. Netherlands $90M - [**Artios**](https://millionrounds.com/company/artios) Artios Pharma Limited is a privately held biotechnology company based in Cambridge, United Kingdom, at the Babraham Research Campus. United Kingdom $83M ### Series C and later 10 startups · $1.4B raised - [**Arcus Biosciences**](https://millionrounds.com/company/arcus-biosciences) Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer. United States $427M - [**Pear Therapeutics**](https://millionrounds.com/company/pear-therapeutics) Pear Therapeutics is a Massachusetts-based prescription digital therapeutic platform that offers solutions such as clinical engage United States $239M - [**Science 37**](https://millionrounds.com/company/science-37) Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers. United States $236M - [**Rani Therapeutics**](https://millionrounds.com/company/rani-therapeutics) Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes. United States $168M - [**Effector Therapeutics**](https://millionrounds.com/company/effector-therapeutics) Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics. United States $99M - [**ONL Therapeutics**](https://millionrounds.com/company/onl-therapeutics) ONL Therapeutics is a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, founded in 2011. United States $67M - [**Cota**](https://millionrounds.com/company/cota) COTA Healthcare is a healthcare technology company focused on oncology real-world data (RWD) and advanced analytics. United States $62M - [**Orionis Biosciences**](https://millionrounds.com/company/orionis-biosciences) Orionis Biosciences is a clinical-stage life sciences company based in Waltham, Massachusetts, with a research facility in Ghent, Belgium. United States $59M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Novartis as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Novartis portfolio map** 68 startups · $7.0B](https://millionrounds.com/portfolio-maps/novartis-portfolio-map)[Investments abroad **Novartis' investments in the United States** 44 startups · $5.8B](https://millionrounds.com/portfolio-maps/novartis-investments-united-states)[Co-investors **Who invests with Novartis** 42 co-investors](https://millionrounds.com/portfolio-maps/novartis-co-investors)[Sector portfolio **Lakestar's AI portfolio** 26 startups · $4.6B](https://millionrounds.com/portfolio-maps/lakestar-ai-portfolio)[Sector portfolio **Lakestar's Fintech portfolio** 20 startups · $7.3B](https://millionrounds.com/portfolio-maps/lakestar-fintech-portfolio)[Sector portfolio **Redalpine's AI portfolio** 16 startups · $701M](https://millionrounds.com/portfolio-maps/redalpine-ai-portfolio) ## Raising from investors like Novartis? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)